1WHO. Global tuberculosis control: surveillance, planning, financing, WHO report 2009[R]. Gerieva:World Health Organization, 2009 : 1-303.
2Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, Nyirencla ST, Binkin NJ, Lucas SB. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998[J]. Int J Tuberc Lung Dis, 2002, 6 (1),55-63.
3Greenberg AE, Lucas S, Tossou O, Coulibaly IM, Coulibaly D, Kassim S, Ackah A, De Cock KM. Auto-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan,Cote d'Ivoire[J]. AIDS, 1995,9(11) : 1251-1254.
4Rana FS, Hawken MP, Mwachari C, Bhatt SM, Abdullah F, Ng‘ang‘a LW, Power C, Githui WA, Porter JD, Lucas SB. Autopsy study of HIV-l-p.ositive and HIV-l-nagative adult medical patients in Nairobi, Kenya [ J ]. J Acquir Immune Defic Syndr, 2000,24(1) :23-29.
5WHO. Interim policy on collaborative TB-HIV activities. Geneva: World Health Organization, 2004.
6Gunneberg C, Reid A, Williams BG, Floyd K, Nunn P. Global monitoring of collaborative TB-HIV aetivities[J]. Int J Tubere Lung Dis, 2008, 12(3) :S2-S7.
